ECOG のPerformance Status PS）の日本語訳

―日本語訳 JCOG

固形がんの治療効果判定のための 新ガイドライン （RECIST ガイドライン） ―日本語訳JCOG版― SPECIAL ARTICLE New Guidelines to Evaluate the Response to Treatment

Common Terminology Criteria for Adverse Events …

1 CTCAE v4.0 - JCOG [CTCAE v4.03/MedDRA v12.0（日本語表記：MedDRA/J v20.1）対応 –2017 年9 月12 日] Common Terminology …

  Meddra

Common Terminology Criteria for Adverse Events …

1 CTCAE v4.0 - JCOG [CTCAE v4.03/MedDRA v12.0（日本語表記：MedDRA/J v13.1）対応 – 2010年9 月11 日] Common Terminology Criteria fo r Adverse Events v4.0 …

  0 jcog, Jcog

「有害事象共通用語規準v4.0日本語訳JCOG 版」（ …

1 「有害事象共通用語規準. v4.0. 日本語訳. jcog. 版」（ ctcae v4.0 - jcog ） 修正・改訂履歴および対応するオリジナル

  0 jcog, Jcog

JCOG0304 - トップページ：日本臨床腫瘍研究 ...

85「 Japan Clinical Oncology Group 骨軟部腫瘍グループ (Bone and Soft Tissue Tumor Study Group) 厚生労働省 厚生労働科学研究費補助金「効果的医療技術の確立推進臨床研究事業」（平成14 年度）

  Jcog0304

National Cancer Institute – Common Toxicity …

CTC 日本語訳JCOG 版/1999 年4 月1 日作成 第2 版/2001 年9 月17日改訂 1 National Cancer Institute – Common Toxicity Criteria (NCI-CTC Version 2.0, April 30, 1999)

  Criteria, Common, Toxicity, Common toxicity, Common toxicity criteria

Common Terminology Criteria for Adverse Events …

1 CTCAE v4.0 - JCOG （CTCAE v4.02/MedDRA v12.0/MedDRA/J v12.1対応 – 2010年2 月1 日） Common Terminology Criteria for Adverse Events v4.0 (CTCAE)

  Criteria, Terminology, Common, Common terminology criteria for

JCOG 1016

JCOG 1016 ver1 .1. 2/106 . 0. 概要. 0.1. シェーマ. 0.2. 目的. 初発退形成性神経膠腫に対して、一次治療として塩酸ニムスチン（

  Jcog

Common Terminology Criteria for Adverse Events …

Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 Published: May 28, 2009 (v4.03: Jun. 14, 2010) 有害事象共通用語規準 v4.0日本語訳JCOG 版（略称：CTCAE v4.0 - JCOG）

  Events, Criteria, Terminology, Common, Adverse, Common terminology criteria for adverse events

婦人科腫瘍グループ： 子宮頸がん治療開発マップ …

婦人科腫瘍グループ： 子宮頸がん治療開発マップ. 2018.2. 対象

Proleukin (aldesleukin) injection label

Eligible patients had an Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) of 0 or 1 and normal organ function as determined by cardiac stress test, pulmonary function tests, and creatinine ≤1.5 mg/dL. Studies excluded patients with brain metastases, active infections, organ allografts and diseases requiring steroid treatment.

  Performance, Group, Cooperative, Status, Oncology, Easterns, Ecog, Performance status, Eastern cooperative oncology group

Appendix III Criteria for Coverage of Exception Status Drugs

lung and with an ECOG performance status 0 or 1. *ALECTINIB (Alecensaro 150mg Capsule) • For the first line treatment of patients with locally advanced or metastatic anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC).

  Performance, Status, Ecog, Ecog performance status

Karnofsky/Lansky Performance Status

Jan 31, 2009 · Karnofsky/Lansky Performance Score vs. ECOG performance score: Some transplant centers may prefer to collect and use the ECOG performance score as opposed to the Karnofsky/Lansky score. Although the ECOG and Karnofsky/Lansky performance score systems are based on similar principles, the scales are not the same. For centers that collect only the ...

  Performance, Status, Ecog, Performance status, Ecog performance

Escalas de estado funcional (o performance status en cáncer

(Karnofsky Performance Status scale; KPS scale o escala KPS) y la escala ECOG (Eastern Cooperative Oncology Group). Además de estas 2 escalas que se utilizan para los pacientes con cáncer, se ha desarro-llado la Escala Paliativa de Funcionalidad (Palliative Performance Scale; PPS o escala PPS), la que está

  Performance, Group, Cooperative, Status, Oncology, Easterns, Ecog, Performance status, Eastern cooperative oncology group

WHO performance status: Lansky/Karnofsky conversion table

The ‘WHO score at diagnosis’ is the performance status of the patient at the moment of diagnosis (synonyms: ECOG/Zubrod score). Although this score is important for all outcome-based analyses (e.g. quality indicators), it is often not determined or registered. In addition, it can be difficult to assign a WHO performance score to children.

  Performance, Status, Ecog, Performance status

COMMONLY USED ABBREVIATIONS AND TERMS in …

ECOG . Eastern Cooperative Oncology Group (Used to determine Performance Status ) EDC . Electronic Data Capture : EMEA . European Agency for the Evaluation of Medicinal Products : FDA . Food and Drug Administration : FWA number . Federal Wide Assurance number (number assigned to IRB )

  Performance, Terms, Used, Group, Cooperative, Status, Oncology, Commonly, Abbreviations, Easterns, Commonly used abbreviations and terms, Ecog, Performance status, Eastern cooperative oncology group

EVIDENCE IN BRIEF

although patients with higher ECOG performance status were eligible for these studies, the majority of patients (~86%) had an ECOG performance status <1. pERC also noted that approximately two-thirds of patients in both studies had prior experience with hydroxyurea, a common treatment for myelofibrosis.

  Performance, Status, Ecog, Ecog performance status

National Cancer Drugs Fund List - NHS England

7. The patient has an ECOG performance status (PS) of 0, 1 or 2. Note: treatment of patients of performance status 2 should only proceed with caution as there is limited safety data on PS 2 patients with urothelial cancer treated with atezolizumab. 8. The patient is ineligible for platinum-based chemotherapy, due to one or more of the following:

  Performance, Drug, Lists, National, Fund, Status, Cancer, Ecog, Performance status, Ecog performance status, National cancer drugs fund list